These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 6774268)

  • 1. [Severe liver damage following administration of valproic acid (Depakine)].
    Coeckelberghs M; van Caillie-Bertrand M; Bultinck J; Clara R
    Ned Tijdschr Geneeskd; 1980 Aug; 124(34):1428-31. PubMed ID: 6774268
    [No Abstract]   [Full Text] [Related]  

  • 2. [Pathogenetic basis of pharmaceutical hepatitis induced by depakine in children].
    Podymova SD; Sadovnikova IV
    Eksp Klin Gastroenterol; 2009; (8):30-5. PubMed ID: 20469676
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Valproic acid-induced idiosyncratic liver injury in 4 cases].
    Xiong H; Liu CT; Zhang YH; Bao XH; Jiang YW; Zhao H; Wu XP; Qin J
    Zhonghua Er Ke Za Zhi; 2012 Dec; 50(12):890-4. PubMed ID: 23324142
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Valproic acid administration for hepatic fibrosis: a balance between antifibrotic efficacy and hepatotoxicity.
    Ikura Y; Iwasa Y; Ueda M
    Hepatology; 2010 Jun; 51(6):2227-8; author reply 2228. PubMed ID: 20513011
    [No Abstract]   [Full Text] [Related]  

  • 5. [Valproic acid induced-idiosyncratic hepatotoxicity].
    Mata Zubillaga D; Prieto Espuñes S; Ferrero de la Mano L; Herrero Mendoza B
    An Pediatr (Barc); 2008 Nov; 69(5):492-3. PubMed ID: 19128756
    [No Abstract]   [Full Text] [Related]  

  • 6. Valproic acid-induced hepatopathy: nine new fatalities in Germany from 1994 to 2003.
    Koenig SA; Buesing D; Longin E; Oehring R; Häussermann P; Kluger G; Lindmayer F; Hanusch R; Degen I; Kuhn H; Samii K; Jungck A; Brückner R; Seitz R; Boxtermann W; Weber Y; Knapp R; Richard HH; Weidner B; Kasper JM; Haensch CA; Fitzek S; Hartmann M; Borusiak P; Müller-Deile A; Degenhardt V; Korenke GC; Hoppen T; Specht U; Gerstner T
    Epilepsia; 2006 Dec; 47(12):2027-31. PubMed ID: 17201699
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatotoxicity and valproate therapy.
    Betrosian A; Frantzeskaki F
    Intern Med J; 2006 Nov; 36(11):752-4. PubMed ID: 17040368
    [No Abstract]   [Full Text] [Related]  

  • 8. [Liver damage caused by valproic acid].
    Stricker BH
    Ned Tijdschr Geneeskd; 1982 Nov; 126(46):2111-3. PubMed ID: 6817146
    [No Abstract]   [Full Text] [Related]  

  • 9. Valproic-acid-induced thrombocytopenia and hepatotoxicity: discontinuation of treatment?
    Lackmann GM
    Pharmacology; 2004 Feb; 70(2):57-8. PubMed ID: 14685007
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Depakene (sodium valproate) in the treatment of epilepsy in children and adolescents: efficiency and safety].
    Petrukhin AS; Mukhin KIu
    Zh Nevrol Psikhiatr Im S S Korsakova; 2001; 101(6):20-7. PubMed ID: 11517881
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Simultaneous toxicities in a child on multiple anticonvulsants.
    Delima SI; Walsh LE; Golomb MR
    J Child Neurol; 2008 Sep; 23(9):1054-7. PubMed ID: 18344455
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Valproic acid-induced DRESS syndrome with acute liver failure.
    van Zoelen MA; de Graaf M; van Dijk MR; Bogte A; van Erpecum KJ; Rockmann H; Maarschalk-Ellerbroek LJ
    Neth J Med; 2012 Apr; 70(3):155. PubMed ID: 22516584
    [No Abstract]   [Full Text] [Related]  

  • 13. [Hepatitis due to antiepileptic agents].
    Davion T; Capron-Chivrac D; Andrejak M; Capron JP
    Gastroenterol Clin Biol; 1985 Feb; 9(2):117-26. PubMed ID: 3920108
    [No Abstract]   [Full Text] [Related]  

  • 14. Nonalcoholic fatty liver disease in adolescents receiving valproic acid.
    Verrotti A; Agostinelli S; Parisi P; Chiarelli F; Coppola G
    Epilepsy Behav; 2011 Feb; 20(2):382-5. PubMed ID: 21256090
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Acute fatal liver insufficiency due to valproic acid therapy].
    Binek J; Hany A; Egloff B; Heer M
    Schweiz Med Wochenschr; 1991 Feb; 121(7):228-33. PubMed ID: 2008603
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical irrelevance of the hematologic side effects of sodium valproate (Depakine)].
    Loisseau P; Martínez-Lage JM
    Rev Med Univ Navarra; 1981 Sep; 25(3):14-6. PubMed ID: 6803320
    [No Abstract]   [Full Text] [Related]  

  • 17. Sodium valproate and hepatotoxicity in epileptics.
    Beran RG; Rischbieth RH
    Med J Aust; 1979 Dec; 2(11):603-4. PubMed ID: 119151
    [No Abstract]   [Full Text] [Related]  

  • 18. Valproic-acid-associated pancreatitis and hepatic toxicity in children with endstage renal disease.
    Levin TL; Berdon WE; Seigle RR; Nash MA
    Pediatr Radiol; 1997 Feb; 27(2):192-3. PubMed ID: 9028861
    [No Abstract]   [Full Text] [Related]  

  • 19. [Is treatment with a daily dose of Depakine Crono safe?].
    Martínez-Salio A; Porta-Etessam J; Berbel A; Manzanares-Secades C; Alvarez-Tejerina J; De La Peña P
    Rev Neurol; 2002 Jun 1-15; 34(11):1095-6. PubMed ID: 12134312
    [No Abstract]   [Full Text] [Related]  

  • 20. Valproate: a simple chemical with so much to offer.
    Peterson GM; Naunton M
    J Clin Pharm Ther; 2005 Oct; 30(5):417-21. PubMed ID: 16164485
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.